« Previous
Next »
Radiotherapy & Oncology
Volume 91, Issue 1
, Pages 49-53
, April 2009
The impact of postmastectomy radiotherapy on local control in patients with invasive lobular breast cancer
References
- The world Health Organization histological typing of breast tumors-Second ed. The World Organization. Am J Clin Pathol 1982;78:806–816.
- . The pathology of invasive breast cancer. A syllabus derived from findings of the national surgical adjuvant breast project (protocol no4). Cancer. 1975;36:1–85
- . An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst. 1975;55:231–273
- . Invasive lobular carcinoma of the breast: incidence and variants. Histopathology. 1979;3:467–488
- Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer. 1996;77:113–120
- Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg. 1995;222:549–559discussion 559-61
- Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma?. Cancer. 1994;73:1673–1677
- Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy. Ann Surg. 2000;231:877–882
- The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy. Breast Cancer Res Treat. 2000;59:49–54
- . Lobular carcinoma of the breast can be managed by breast-conserving therapy. Br J Surg. 1995;82:1364–1366
- . Lumpectomy and radiation treatment for invasive lobular carcinoma of the breast. Am J Surg. 1996;172:496–500
- . Optimal surgical treatment of invasive lobular carcinoma of the breast. Ann Surg Oncol. 1997;4:545–550
- . Treatment trends in early-stage invasive lobular carcinoma: a report from the national cancer data base. Ann Surg. 2005;242:281–289
- . Margin status and the risk of local recurrence after breast-conserving treatment of lobular breast cancer. Breast Cancer Res Treat. 2007;105:63–68
- Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol. 2001;19:1688–1697
- Adjuvant systemic therapy for patients with resectable breast cancer: guideline from the Dutch National Breast Cancer Platform and the Dutch Society for medical oncology. Ned Tijdschr Geneeskd. 2000;144:984–989
- . Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst. 1998;90:1601–1608
- Goldhirsch A, Glick JH, Gelber RD, Coates AS, Senn HJ. Meeting highlights: international consensus panel on the treatment of primary breast cancer. Seventh international conference on adjuvant therapy of primary breast cancer. J Clin Oncol 2001;19:3817–3827.
- An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast. Eur J Surg Oncol. 1991;17:251–257
- . Surgical treatment for invasive lobular carcinoma of the breast. Breast. 2003;12:23–35
- . Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol. 2007;82:247–253
- Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study. Int J Radiat Oncol Biol Phys. 2006;64:1081–1091
PII: S0167-8140(08)00513-6
doi: 10.1016/j.radonc.2008.09.012
© 2008 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Radiotherapy & Oncology
Volume 91, Issue 1
, Pages 49-53
, April 2009
